fda ban tirzepatide 🚨 Important Update on Compounded 🚨, As of March 19th, the has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA Drug Recalls and Warnings:

But the retatrutide molecule weighs approximately 4,895 daltons, and that molecular weight creates absorption challenges that every researcher needs to understand before pursuing this route

Both strategies are proving far more effective than single-target GLP-1 agonism

The worlds largest company for diabetes treatments alleges illegal marketing and sales practices by third-parties created a high risk of consumer confusion and deception as well as potential safety concerns considering compounded products do not have the same safety, quality and effectiveness assurances that its products, approved by Food and Drug Administration (FDA), do

Fras JP, Davies MJ, Rosenstock J, et al